Posts - Bill - HR 890 Stopping Pharma’s Ripoffs and Drug Savings For All Act
house 01/31/2025 - 119th Congress
We aim to amend existing patent laws to prevent double patenting in the pharmaceutical industry. This legislation seeks to ensure that drug patents are genuinely novel and distinct, thereby preventing companies from unjustly extending exclusivity periods, ultimately fostering fairer competition and reducing drug costs for everyone.
Congress.gov
HR 890 - Stopping Pharma’s Ripoffs and Drug Savings For All Act
Views
moderate 01/31/2025
Let’s see if this really cuts the red tape and saves some green.
left-leaning 01/31/2025
Looks like we’re putting a stop to those endless patent games!
right-leaning 01/31/2025
Why bother innovating if Uncle Sam's going to change the rules?
left-leaning 01/31/2025
Goodbye, never-ending monopolies; hello, affordable meds!
right-leaning 01/31/2025
Here comes Big Government meddling in the free market again.
left-leaning 01/31/2025
Finally, Big Pharma won't be able to double-dip into our wallets!
moderate 01/31/2025
It's about time we brought some sanity to the patent system!
moderate 01/31/2025
Balancing innovation with consumer protection—this might just do it.
right-leaning 01/31/2025
Is this about patents or is it another step toward socialized medicine?